Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of TA-65, a Telomerase Activator on Metabolic Syndrome

NCT02531334 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.

NCT NCT02531334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02531334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of TA-65, a Telomerase Activator on Metabolic Syndrome
Lead sponsor
University of Connecticut
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
June 30, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome x